Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 2

Conditions

Prostatic Neoplasms 13Lymphoma, Large B-Cell, Diffuse 12Burkitt Lymphoma 12Lymphoma, Follicular 8Lymphoma, Non-Hodgkin 6Lymphoma 6Neoplasms 5Prostatic Neoplasms, Castration-Resistant 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, B-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmablastic Lymphoma 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Triple Negative Breast Neoplasms 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Multiple Myeloma 1Multi-centric Castleman's Disease 1Metastatic Castration-sensitive Prostate Cancer 1Metastatic Castration-resistant Prostate Neoplasms 1Macular dystrophy, corneal type 1 1Lymphoma, Mantle-Cell 1Lymphadenopathy 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Hairy Cell 1

Interventions

Cyclophosphamide 8Mycophenolic Acid 6Whole-Body Irradiation 5Busulfan 5fludarabine phosphate 4fludarabine 4Tacrolimus 4Cyclosporine 4Rituximab 3Prednisone 3Methotrexate 3Inotuzumab Ozogamicin 3Etoposide 3Cytarabine 3venetoclax 2ruxolitinib 2pegfilgrastim 2asciminib 2Vincristine 2Peripheral Blood Stem Cell Transplantation 2Mercaptopurine 2Filgrastim 2Dexamethasone 2Calcium Dobesilate 2tocilizumab 1ricolinostat 1rasburicase 1ponatinib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Leukemia × Prednisone × 30 days × Clear all
NCT04747912 2026-06-05

Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

University of Chicago

Phase 2 Recruiting
25 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01046825 2026-06-02

Mature B-Cell Lymphoma And Leukemia Study III

St. Jude Children's Research Hospital

Phase 2/3 Active not recruiting
128 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

NCT05645718 2026-05-19

Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia

M.D. Anderson Cancer Center

Phase 2 Recruiting
27 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡